Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Viviana Lacava, Vincenzo Pellicanò, Carmen Ferrajolo, Valeria Cernaro, Luca Visconti, Giovanni Conti, Michele Buemi & Domenico Santoro. (2017) Novel avenues for treating diabetic nephropathy: new investigational drugs. Expert Opinion on Investigational Drugs 26:4, pages 445-462.
Read now
Read now
Percy H Carter. (2013) Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 – 2012. Expert Opinion on Therapeutic Patents 23:5, pages 549-568.
Read now
Read now
Juan Antonio Moreno, Sara Moreno, Alfonso Rubio-Navarro, Cristina Sastre, Luis Miguel Blanco-Colio, Carmen Gómez-Guerrero, Alberto Ortiz & Jesús Egido. (2012) Targeting chemokines in proteinuria-induced renal disease. Expert Opinion on Therapeutic Targets 16:8, pages 833-845.
Read now
Read now
Articles from other publishers (14)
Chenglin Lu, Ying Liu, Nasra Mohamoud Ali, Bin Zhang & Xiaonan Cui. (2023) The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. Frontiers in Immunology 13.
Crossref
Crossref
Bei Li, Siqing Liu, Qian Yang, Zhiyu Li, Juanjuan Li, Juan Wu, Shengrong Sun, Zhiliang Xu, Si Sun & Qi Wu. (2022) Macrophages in Tumor‐Associated Adipose Microenvironment Accelerate Tumor Progression. Advanced Biology 7:1, pages 2200161.
Crossref
Crossref
Jianxin Wang, May Tun Saung, Keyu Li, Juan Fu, Kenji Fujiwara, Nan Niu, Stephen Muth, Junke Wang, Yao Xu, Noah Rozich, Haley Zlomke, Sophia Chen, Birginia Espinoza, MacKenzie Henderson, Vanessa Funes, Brian Herbst, Ding Ding, Christina Twyman-Saint Victor, Qihong Zhao, Amol Narang, Jin He & Lei Zheng. (2022) CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma. Journal of Experimental Medicine 219:5.
Crossref
Crossref
Xue Song, Yangxu Chen, Fangfang Lu, Kai Zhang, Chenxia Yu, Tuanjie Li & Changsheng Yao. (2022) NHC-catalyzed [4 + 2] annulations of allenoates and 2,3-dioxopyrrolidine derivatives. Organic & Biomolecular Chemistry 20:6, pages 1219-1225.
Crossref
Crossref
Jie Long, Jiemei Chen, Qingchun Wang, Feng Gao, Ming Lian, Peng Zhang, Yuejin Yang & Haibo Zhu. (2020) NFAT activating protein with ITAM motif 1 (NFAM1) is upregulated on circulating monocytes in coronary artery disease and potentially correlated with monocyte chemotaxis. Atherosclerosis 307, pages 39-51.
Crossref
Crossref
Bayard R. Huck, Lisa Kötzner & Klaus Urbahns. (2018) Small Molecules Drive Big Improvements in Immuno-Oncology Therapies. Angewandte Chemie International Edition 57:16, pages 4412-4428.
Crossref
Crossref
Bayard R. Huck, Lisa Kötzner & Klaus Urbahns. (2018) Kleine Moleküle, ganz groß: niedermolekulare immunonkologische Kombinationstherapien. Angewandte Chemie 130:16, pages 4499-4516.
Crossref
Crossref
Felicia Phei Lin Lim, Nathan R. Halcovitch, Edward R.T. Tiekink & Anton V. Dolzhenko. (2018) A new microwave-assisted, three-component reaction of 5-aminopyrazole-4-carboxylates: Selective synthesis of substituted 5-aza-9-deaza-adenines. Tetrahedron 74:15, pages 1868-1879.
Crossref
Crossref
Ji Hye Huh, Hong Min Kim, Eun Soo Lee, Mi Hye Kwon, Bo Ra Lee, Hyun-Jeong Ko & Choon Hee Chung. (2018) Dual CCR2/5 Antagonist Attenuates Obesity-Induced Insulin Resistance by Regulating Macrophage Recruitment and M1/M2 Status. Obesity 26:2, pages 378-386.
Crossref
Crossref
Satish Kumar Devarapu, Santhosh Kumar VR, Khader Valli Rupanagudi, Onkar P. Kulkarni, Dirk Eulberg, Sven Klussmann & Hans-Joachim Anders. (2017) Reprint of “Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis”. Clinical Immunology 185, pages 119-127.
Crossref
Crossref
Satish Kumar Devarapu, Santhosh Kumar VR, Khader Valli Rupanagudi, Onkar P. Kulkarni, Dirk Eulberg, Sven Klussmann & Hans-Joachim Anders. (2016) Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis. Clinical Immunology 169, pages 139-147.
Crossref
Crossref
Felicia Phei Lin Lim & Anton V. Dolzhenko. (2014) 1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry. European Journal of Medicinal Chemistry 85, pages 371-390.
Crossref
Crossref
Gemma E. White, Asif J. Iqbal & David R. Greaves. (2013) CC Chemokine Receptors and Chronic Inflammation—Therapeutic Opportunities and Pharmacological Challenges. Pharmacological Reviews 65:1, pages 47-89.
Crossref
Crossref
Maikel Wijtmans, Danny J. Scholten, Iwan J.P. de Esch, Martine J. Smit & Rob Leurs. (2012) Therapeutic targeting of chemokine receptors by small molecules. Drug Discovery Today: Technologies 9:4, pages e229-e236.
Crossref
Crossref